Location History:
- Ludwigshafen, DE (2011 - 2013)
- Gönnheim, DE (2015)
- Gonnheim, DE (2013 - 2018)
Company Filing History:
7 out of 822 
7 out of 167 
4 out of 140 
Years Active: 2011-2018
Title: Innovations of Ana-Lucia Relo
Introduction
Ana-Lucia Relo is an accomplished inventor based in Gonnheim, Germany, with a remarkable portfolio of 11 patents to her name. Her work primarily focuses on the development of novel pharmaceutical compounds that modulate serotonin receptors, which have significant implications for treating various disease conditions.
Latest Patents
Among her notable inventions is a series of patents related to modulators of 5-HT receptors. The first patent describes aryl- and heteroaryl-fused compounds including decahydropyrroloazepine, octahydrooxepinopyrrole, and other derivatives. These compounds are crucial for developing compositions aimed at treating disorders linked to serotonin signaling pathways.
Another significant patent from Ana-Lucia Relo involves complexes such as 1,2,3,4,4a,5,6,7-octahydropyrazino[1,2-a][1,4]benzodiazepine and other innovative derivatives. She outlines not only the compounds themselves but also methods of producing these compounds and their application in therapeutic settings.
Career Highlights
Ana-Lucia has had a significant impact in the pharmaceutical industry, contributing her expertise at well-known companies such as AbbVie Inc. and AbbVie Deutschland GmbH & Co. KG. Her career showcases a blend of scientific innovation and practical application in the healthcare sector, making her a valuable asset in her field.
Collaborations
During her career, Ana-Lucia has collaborated with talented coworkers, including Frauke Pohlki and Min Zhang. These partnerships have enhanced her research efforts and expanded the scope of her developments, leading to groundbreaking advancements in therapeutic methods.
Conclusion
Ana-Lucia Relo's contributions to science and medicine through her innovations in serotonin receptor modulators highlight her role as a pivotal inventor in her field. With her impressive portfolio of patents and collaborative efforts, she continues to pave the way for future advancements in pharmaceutical applications.